A newly published study in the International Journal of Gynecology & Obstetrics offers a resounding yes.
Researchers evaluated the HemoClear microfiltration system in cesarean sections at a South African tertiary hospital, and the results are compelling.
Key findings and clinical highlights
🩸75.5% erythrocyte recovery, with strong platelet retention
🩸Safe bacterial profile and >75% removal of α-fetoprotein, supporting reinfusion safety
🩸No electricity, centrifuge, or costly equipment needed
🩸Filtration completed in ~15 minutes, making it workflow-compatible
The authors conclude that HemoClear could significantly enhance obstetric care in LMICs, where blood shortages and transfusion risks are prevalent. This gravity-driven solution offers affordable, portable, and practical cell salvage, exactly where it’s needed most.
📄 Full article: https://bit.ly/4eUteeD
